Oritsegbubemi Omatseyin Lagos — The Nigeria Customs Service, NCS, has announced that President Bola Ahmed Tinubu, through the Minister of Finance and Coordinating Minister of the Economy, Adebayo Olawale Edun, has approved comprehensive guidelines to actualise objectives aimed at enhancing local manufacturing of healthcare products, reducing the costs of medical equipment and consumables, as well as stimulating local investments.
Critical raw materials essential for the production of pharmaceutical products will be exempted from import duty and Value Added Tax, VAT, for a period of two years. This exemption covers Active Pharmaceutical Ingredients, APIs, excipients, and other vital raw materials required for manufacturing essential medicines, Long-Lasting Insecticidal Nets, LLINs, Rapid Diagnostic Kits, reagents, and packaging materials.
To ensure that these fiscal incentives are fully utilised, eligibility is limited to manufacturers of pharmaceutical products recognised by the Federal Ministry of Health and Social Welfare, provided they possess a valid Tax Identification Number, TIN. This measure ensures that the benefits directly support legitimate manufacturers committed to strengthening Nigeria’s healthcare infrastructure.
In commitment to transparency and effective monitoring, the NCS will compile quarterly reports detailing all importations under this policy, including data on importers, quantities, and values of the imported items, ensuring the policy’s implementation aligns with its intended objectives.
The Nigeria Customs Service remains committed to supporting government policies while fulfilling its mandate to facilitate trade, enhance border security, and drive national development.
Successful implementation of this policy requires collaboration from all stakeholders, including importers, manufacturers, and relevant government agencies. Through collective efforts, the goal of a robust healthcare sector that meets the needs of all Nigerians can be achieved.
